We apologise for any inconvenience and thank you for your understanding.
Dont let it freeze, though
Triple receptor activity: GLP-1, GIP, and glucagon Appetite and satiety pathway support Energy expenditure and fat metabolism research Body weight reduction in clinical trials Potential metabolic health improvements A possible future option for clients who have plateaued on existing therapies In a phase 2 trial published in The New England Journal of Medicine, adults with obesity who received Retatrutide for 48 weeks had substantial reductions in body weight, with the 12 mg group showing a mean percentage change of -24.2% compared with -2.1% for placebo
Choose water, unsweetened tea, and electrolyte-enhanced beverages over sugary drinks
While semaglutide can potentially be used in combination with other weight loss medications, this approach should be navigated with caution
Maintain consistent calorie intake if you are testing for body composition or use a modest calorie deficit if your goal is fat loss